Passage BIO (PASG) Treasury Shares (2019 - 2026)
Passage BIO (PASG) posted quarterly Treasury Shares of $25000.0 for Q1 2026, down 98.0% year-over-year from $1.2 million in Q1 2025, and down 50.0% quarter-over-quarter from $50000.0 in Q4 2025.
Passage BIO (PASG) Treasury Shares (2019 - 2026) Analysis & Trends
Passage BIO's Treasury Shares history runs 7 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- In Q1 2026, Treasury Shares fell 98.0% year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $25000.0 (down 98.0% YoY), while the FY2025 annual figure was $50000.0, up 604.92% from the prior year.
- Treasury Shares for Q1 2026 stood at $25000.0, down from $50000.0 in the prior quarter.
- The five-year high for Treasury Shares was $1.2 million in Q1 2025, with the low at $7093.0 in Q4 2024.
- The 5-year median for Treasury Shares is $409500.0 (2022), against an average of $556578.9.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares slumped 99.23% in 2024, then surged 604.92% in 2025.
- Passage BIO's Treasury Shares stood at $1.2 million in 2022, then decreased by 24.58% to $927000.0 in 2023, then plunged by 99.23% to $7093.0 in 2024, then soared by 604.92% to $50000.0 in 2025, then slumped by 50.0% to $25000.0 in 2026.
- Business Quant data shows PASG's Treasury Shares at $25000.0 in Q1 2026, $50000.0 in Q4 2025, and $52500.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 2.72 Mn |
| 10 | Passage BIO | 13.96 Mn | 13.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,000.00 |
| Jun 30, 2026 | 15,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 52,500.00 |
| Sep 30, 2025 | 52,500.00 |
| Jun 30, 2025 | 52,500.00 |
| Jun 30, 2025 | 52,500.00 |
| Mar 31, 2025 | 1.25 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 7,093.00 |
| Dec 31, 2024 | 7,093.00 |
| Sep 30, 2024 | 330,167.00 |
| Sep 30, 2024 | 330,167.00 |
| Jun 30, 2024 | 352,667.00 |
| Jun 30, 2024 | 352,667.00 |
| Mar 31, 2024 | 400,167.00 |
| Mar 31, 2024 | 400,167.00 |